Traws Pharma risks Nasdaq delisting after shares trade below $1 for 30 days

• Traws Pharma received a Nasdaq notice on July 29, 2026 for failing the $1 minimum bid price rule on Nasdaq Capital Market.
• Non-compliance followed at least 30 consecutive business days with the closing bid below $1; the stock remains listed.
• Deadline to regain compliance is Jan. 25, 2027; requires a closing bid at or above $1 for 10 consecutive business days.
• Failure to cure could trigger a delisting notice; a second 180-day grace period may be available if other listing standards are met.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Traws Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-089220), on July 31, 2026, and is solely responsible for the information contained therein.